Meta-analytical results of secondary outcomes. حسب Maria-Sophie Brueckle (13816408)

الموضوعات:

Study characteristics. حسب Maria-Sophie Brueckle (13816408)

الموضوعات:

Forest plots of primary outcomes. حسب Maria-Sophie Brueckle (13816408)

الموضوعات:

Detection of the Challenging mutations at 1% VAF and 50 ng DNA input. حسب Lizhi Yu (12476136)

الموضوعات:

ngLVA degradation kinetics. حسب Nicole A. Grieshaber (11175417)

Metformin lotion decreases TGF-β1 levels in the wounded skin of rats after 10 days of wound healing. حسب Jianying Zhang (256508)

الموضوعات:

Excision of HIF1α decreases viral reactivation from latency in infected splenocytes in vivo. حسب Darlah M. López-Rodríguez (8098544)

Knock-down of Atox1 in SW620 cells decreased cell migration and colony formation. حسب Arundhati Jana (157555)

Triiodothyroacetic acid (TRIAC), thyroxine (T4) and 3,5,3’-triiodothyronine (T3) levels in plasma of vehicle treated wild type (Wt; TRIAC n = 5; T4 n = 5; T3 n = 5 and TSH n = 4) a... حسب Soledad Bárez-López (607514)

Mean decrease in accuracy (MDA) of top 15 urine metabolites. حسب Liam E. Broughton-Neiswanger (8447220)

"…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…"

Clinical evolution at 30 days in the different treatment groups. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

SaFi, laboratory, radiology, vaccine status, and inpatient treatment data. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

Relationship between a simplified SCOPE score at start of treatment with anakinra and clinical outcome at 60 days. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

Probability of medical discharge at 60 days in the different treatment groups. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

Clinical outcome at 60 days based on SaFi, anakinra and a simplified SCOPE. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

Comorbidities and severity scales at admission for the different treatment groups. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

Probability of remaining as an inpatient at 30 days in the different treatment groups. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

Probability of medical discharge at 30 days in the different treatment groups. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

Probability of remaining as an inpatient at 60 days in the different treatment groups. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات:

A simplified SCOPE score. حسب Ismael Francisco Aomar-Millán (14838595)

الموضوعات: